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Abstract 
 
The human aryl sulfotransferases HAST4 and HAST4v vary by only two amino acids but exhibit 
markedly different affinity towards the sulfonate acceptor p-nitrophenol and the sulfonate donor 
3%-phosphoadenosine-5%-phosphosulfate (PAPS). To determine the importance of each of 
these amino acid differences, chimeric constructs were made of HAST4 and HAST4v. By 
attaching the last 120 amino acids of HAST4v to HAST4 (changing Thr235 to Asn235) we have 
been able to produce a protein that has a Km for PAPS similar to HAST4v. The reverse 
construct, HAST4v:4 produces a protein with a Km for PAPS similar to HAST4. These data 
suggests that the COOH-terminal of sulfotransferases is involved in co-factor binding.  
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Introduction 
 
Sulfonation is an important metabolic pathway involved in the detoxification and:or activation of a range of 
endogenous compounds (e.g. monoamine neurotransmitters, thyroid and steroid hormones), drugs (e.g. minoxidil) 
and xenobiotics (e.g. aromatic amines and benzylic alcohols of polycyclic aromatic hydrocarbons) [1]. This reaction 
involves transfer of a sulfonate group from the 3%-phosphoadenosine- 5%-phosphosulfate (PAPS) to the acceptor 
substrate. In the case of xenobiotics, this reaction is catalysed by a group of cytosolic sulfotransferase enzymes 
(STs). However, it is important to recognise that a number of membrane bound STs also exist [2]. Based on amino 
acid alignments, the cytosolic sulfotransferases have been divided into three families: phenol, hydroxysteroid and 
flavonol STs [2]. In the laboratory, five human aryl (phenol) STs have been cloned: HAST1, HAST2, HAST3, 
HAST4 and HAST4v. HAST1, HAST4 and HAST4v were isolated from a liver cDNA library, whereas HAST2 and 
HAST3 were obtained from a brain cDNA library [3–5]. 
All of the human aryl STs share greater than 90% sequence homology at the amino acid level but vary 
markedly in their substrate preferences. For example, HAST1 and HAST3 are 93% identical at the amino acid level 
but their affinity (Km) for p-nitrophenol is 0.6 and 2200 mM, respectively (Table 1) [6]. HAST4 metabolises p-
nitrophenol with an intermediate affinity (Km 74 mM) compared to HAST1 and HAST3 but it exhibits no activity 
towards dopamine as a substrate (Table 1) [5]. A variant of HAST4 (HAST4v) shows significantly higher affinity 
for p-nitrophenol and the co-factor PAPS than HAST4 (Table 1) [5]. These allelic variants differ by only two amino 
acids (HAST4: Thr-7 and Thr-235 and HAST4v: Ile-7 and Asn-235) [5]. Human aryl sulfotransferases, like many 
other xenobiotic metabolising enzymes (e.g., P450s), exhibit overlapping substrate specificities at high substrate 
concentrations which are probably not relevant from a physiological viewpoint (e.g., HAST1 has a Km for dopamine 
of 345 mM).  At the present time, except for the data on HAST4:HAST4v, there is no information available to 
explain the catalytic diversity of human aryl STs. It is still unclear what influence the amino acid sequence of each 
form of ST has on its distinct substrate specificities and the binding of the co-factor PAPS. A crystal structure for a 
ST is yet to be published and this has hindered the understanding of the structural and functional relationships of 
these enzymes. The recent cloning of an increasing number of sulfotransferases from a variety of species and 
analysis of their amino acid sequences has revealed at least four highly conserved regions [2,7]. A number of 
laboratories have now utilised this data to construct chimeric cDNAs and perform site-directed mutagenesis on these 
regions, as well as carry out affinity labelling to gain insight into the substrate and PAPS binding sites of guinea pig 
[8,9], rat [10] and plant [7,11] STs. It has been suggested that the PAPS binding region resides in a highly conserved 
Chemico-biological Interactions (1998) 109 (1-3), 123-127. doi: 10.1016/S0009-2797(97)00126-9 
 
GXXGXXK motif at the C-terminal end of STs [8,9]. Site-directed mutagenesis within this region (GISGDWKN) in 
the guinea pig estrogen sulfotransferase markedly affected the Km for PAPS and confirmed this part of the amino 
acid sequence to be a critical component of the active site [9]. Marsolais and Varin have determined by site-directed 
mutagenesis of the flavonol 3-sulfotransferase that Arg276, which is in close proximity to the suggested 
GXXGXXK motif, is crucial for PAPS binding [7]. This arginine residue is conserved amongst all the known 
cytosolic STs and supports the initial observation by Borchardt et al. of the importance of arginine residue(s) in the 
sulfonate transfer reaction [12,13]. Studies by Zheng et al. which have used an affinity labelling approach to study 
PAPS binding on a rat aryl sulfotransferase have found the amino acid sequence 63-Leu-Glu-Lys-Cys-Gly-Arg-68 
in region I to be present at the PAPS binding site [10]. In the flavonol 3-sulfotransferase mutation of Lys59 (also in 
region I) has shown this amino acid to be critical for catalysis but not PAPS binding [7]. It is possible to speculate 
that within the three dimensional structure of STs, interactions between the different regions may be critical for 
determining both PAPS and substrate binding. 
 
 
 
Chimeric constructs of HAST4 and HAST4v 
 
As described earlier, HAST4 and HAST4v vary by only two amino acids but exhibit markedly different affinity 
towards the sulfonate acceptor p-nitrophenol and the sulfonate donor PAPS (Table 1). To determine the importance 
of each of these amino acid differences, chimeric constructs were made of HAST4 and HAST4v. This was done by 
using a common PmlI restriction site and a XbaI site in the poly linker of pCMV5. This enables us to exchange the 
last 120 amino acids of HAST4 with the same portion of HAST4v (HAST4:HAST4v construct) and similarly the 
last 120 amino acids of HAST4v with the same portion of HAST4 (HAST4v: HAST4 construct). When the above 
chimeric constructs were expressed in COS cells they encoded proteins on immunoblots of identical molecular 
weights to HAST4 and HAST4v. The Foldes and Meek assay [14] was used to determined the Michaelis–Menten 
parameters, Km (Table 1) and Vmax, of the native HAST4 and HAST4v for p-nitrophenol and PAPS, respectively, as 
well as the two chimeric constructs HAST4:HAST4v and HAST4v:HAST4. HAST4v has a higher affinity for both 
p-nitrophenol and PAPS compared to HAST4. For example, HAST4v has a 26-fold lower Km than HAST4 for PAPS 
as the substrate. Since HAST4 and HAST4v vary by only two amino acids, it is suggestive that these amino acid 
changes reside close to the substrate and co-factor binding domains. However, the change at position 235 in 
HAST4v compared to HAST4 involves a conservative substitution of an Asn for a Thr. This change is in close 
proximity to the putative PAPS binding domain [3,8,9] and resides within a region that shows subtle differences in 
amino acid differences between HAST1, HAST3 and HAST4 proteins. From Table 1 it is apparent that by attaching 
the last 120 amino acids of HAST4v to HAST4 it was possible to produce a protein that has a Km for PAPS similar 
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to HAST4v. The reverse construct, HAST4v:HAST4, where a Thr is at position 235, produces a protein with a Km 
for PAPS similar to HAST4. These data suggests that the COOH-terminal of sulfotransferases is involved in co-
factor binding. The presence of an Asn at position 235 in HAST4v and HAST4:HAST4v, compared to a Thr in 
HAST4 and HAST4v:HAST4, also affected the Km for p-nitrophenol and these data like that of Driscoll et al. [9] 
supports the assumption that critical substrate binding elements also reside in an area where the co-factor PAPS 
binds. The above data confirm that critical amino acid changes can markedly alter the affinity of HAST proteins for 
both PAPS and p-nitrophenol. Further studies on structural and functional relationships between human 
sulfotransferases are currently under investigation. 
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